Matthew Betts

Dr. Matthew Betts is a researcher specializing in neuroscience, with a focus on neuroimaging, noradrenergic/dopaminergic systems, and neurodegenerative diseases like Alzheimer's. His work primarily involves collaborative projects under SFB 1315, investigating biomarkers, cognitive aging, and MRI/PET methodologies.

Research interests span the role of noradrenaline and dopamine in memory consolidation, neuromodulation techniques (e.g., transcutaneous vagus nerve stimulation), and the development of imaging standards for brainstem structures. His studies frequently explore links between neurotransmitter dysfunction and pathologies like Alzheimer's and Parkinson's disease.

Publications emphasize advanced MRI applications, CSF biomarkers, and computational modeling to decode neurodegenerative mechanisms. Collaborative frameworks dominate his output, highlighting interdisciplinary approaches to brain aging.

No awards, students, or grants are detailed in available texts. Betts contributes to teams at institutions like Humboldt-Universität zu Berlin, focusing on translational neuroscience.